Skip to content

A prospective, observational study of quality of life in patients with high-risk non-muscular invasive bladder cancer during intravesical treatment after surgery

A prospective, observational study of quality of life in patients with high-risk non-muscular invasive bladder cancer during intravesical treatment after surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075046
Enrollment
Unknown
Registered
2023-08-23
Start date
2024-01-01
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma of bladder

Interventions

case series:None

Sponsors

Lishui Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age =18 years old;2. Surgical pathology confirmed high risk non-muscular invasive urothelial carcinoma of bladder;3. Patients or family members can use smart phones or tablet computers to fill in the information, and have certain understanding ability to fill in the scale;4. Uniformly sign informed consent;

Exclusion criteria

Exclusion criteria: 1. Patients with other systemic tumors; 2. Patients with lower urinary tract symptoms before surgery; 3. Patients with mental illness before surgery; 4. There are other serious diseases that affect follow-up, such as serious cardiovascular and cerebrovascular diseases; 5. Patients who cannot cooperate; 6. Patients who are unwilling to sign informed consent;

Design outcomes

Primary

MeasureTime frame
Quality of life scale for patients during intravesical treatment after surgery for high-risk non-muscular invasive bladder cancer;Progression-free survival and recurrence-free survival at 12 months after surgery for high-risk non-invasive bladder cancer;

Secondary

MeasureTime frame
utility parameters;

Countries

China

Contacts

Public ContactGu Tengfei

Lishui Central Hospital

gutengfei521@163.com+86 151 6804 8275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026